SCHEMBL3635971

SCHEMBL3635971

C1CCC([C](CC2CCCC2)CC2CC2)CC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.40
HPGD P15428 2/20 0.40
KMT2A Q03164 1/20 0.40
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
ADH1B P00325 1/20 0.34
ADH1C P00326 1/20 0.34
ADH1A P07327 1/20 0.34
ADH4 P08319 1/20 0.34
ADH7 P40394 1/20 0.34
EPHX2 P34913 1/20 0.33
MGLL Q99685 1/20 0.33
HSD11B1 P28845 1/20 0.32
CHRM5 P08912 2/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
CYP1A2 P05177 1/20 0.32
ADRA2C P18825 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6388427 0.97 EPHX1 (0.41) EPHX1HPGDKMT2ACES2CES1
SCHEMBL8602663 0.95 EPHX1 (0.35) EPHX1HPGDKMT2ACES2CES1
SCHEMBL4224634 0.83 CYP1A2 (0.38) EPHX1HPGDKMT2ACES2CES1
SCHEMBL4449483 0.83 CYP1A2 (0.38) EPHX1HPGDKMT2ACES2CES1
SCHEMBL3659402 0.83 CYP1A2 (0.38) EPHX1HPGDKMT2ACES2CES1
SCHEMBL11653900 0.83 CYP1A2 (0.38) EPHX1HPGDKMT2ACES2CES1
SCHEMBL11402454 0.77 EPHX1 (0.39) EPHX1HPGDKMT2ACES2CES1
SCHEMBL8027760 0.77 ALDH1A1 (0.34) EPHX1
SCHEMBL20815399 0.76 EPHX1 (0.41) EPHX1HPGDKMT2ACES2CES1
SCHEMBL1936361 0.72 EPHX1 (0.39) EPHX1HPGDKMT2ACES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155719-A1 AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS Wyeth LLC (US) 2010-02-24 EP disclosed
WO-2008147945-A1 AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS WYETH (US) 2008-12-04 WO disclosed